Harman Patil (Editor)

Amonafide

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Trade names
  
Xanafide, Quinamed

CAS Number
  
69408-81-7

ChemSpider
  
45804

Molar mass
  
283.325 g/mol

ATC code
  
none

PubChem CID
  
50515

UNII
  
1Q8D39N37L

Amonafide httpsuploadwikimediaorgwikipediacommonsthu

Amonafide (originally AS1413) (INN, trade names Quinamed and Xanafide) is a drug that is being studied in the treatment of cancer. It belongs to a novel family of chemotherapeutic drugs called Naphthalimides and is a potential topoisomerase inhibitor and DNA intercalator.

It is being developed as an anti-cancer therapy by Antisoma.

As of 2008, it is in Phase III clinical trials. e.g. In March 2010 it is Phase III trial against secondary acute myeloid leukaemia (AML). In June 2010, it gained an FDA Fast Track Status for the treatment of Secondary Acute Myeloid Leukaemia.

How to pronounce amonafide


References

Amonafide Wikipedia